Companies: 10,795·Total market cap: $144.5T

Innovation Pharmaceuticals Inc.

Innovation Pharmaceuticals Inc.

IPIXOTCHealthcare● Active

$0.00

+$0.00(+0.00%)

Market Cap$155504

P/E Ratio—

52W High$0.05

52W Low$0.00001

Avg Volume113K

Open$0.00

Beta-0.49

Net Income Financials Revenue

Innovation Pharmaceuticals Inc. (IPIX) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

IPIX · net income · updated Jun 9, 2026

Core profitability metrics

IPIX · net income · margin · TTM · CAGR

Net income was −$3.2M for FY2023 (fiscal year ending 2023-06-30), up 55.0% year-over-year. Net profit margin was —.

FY2023 Net Income−$3.2M▲ +55.0% YoY

Trailing 12M (TTM)−$2.7Mtrailing 4 quarters sum

Net Profit Margin——

YoY Change+55.0%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %

▸ FMP /income-statement · Annual · IPIX net income history · IPIX profit margin

Annual net income data

IPIX · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2023Loss−$3.2M▲ +55.0%—$0

FY2022Loss−$7.0M▲ +49.2%-39116.7%$18,000

FY2021Loss−$13.9M▼ 108.7%—$0

FY2020Loss−$6.6M▲ +26.7%-1571.6%$423,000

FY2019Loss−$9.1M▲ +44.6%—$0

Net income vs peers (Healthcare)

IPIX vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

#1

Innovation Pharmaceuticals Inc.YOU

IPIX

−$3.2M+55.0%—

Loss

Johnson & Johnson

$26.80B+90.6%28.5%

Eli Lilly and Company

$20.64B+94.9%31.7%

UnitedHealth Group Incorporated

$12.06B-16.3%2.7%

$4.23B-1.2%6.9%

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Innovation Pharmaceuticals Inc. (IPIX) reported net income of −$3.2M for FY2023 (fiscal year ending 2023-06-30), up 55.0% year-over-year. The net profit margin was — — meaning the company kept $— of every dollar of revenue as profit.

Innovation Pharmaceuticals Inc. has not yet achieved annual profitability based on available data (15 fiscal years). The company has reported net losses across all available periods.

Innovation Pharmaceuticals Inc.'s net profit margin was — for FY2023, based on the latest annual results.

Investors sometimes search for "Innovation Pharmaceuticals Inc. net worth" — the company's market capitalization is a separate figure from IPIX net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

IPIX net income · 4 questions

Innovation Pharmaceuticals Inc. is not currently profitable on an annual basis. The company reported a net loss of $3.2M for FY2023.

is IPIX profitabledoes IPIX make a profitIPIX profitabilityIPIX profitable company

▸ Source: FMP /income-statement · GAAP · Innovation Pharmaceuticals Inc. · Innovation Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026